|
|
|
 |
|
|
 |
 |
Cell Genesys, Inc.
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Cell Genesys, Inc.. The Group's principal activities are researching, developing and commercializing novel biological therapies for patients with cancer. It currently has three product platforms: GVAX cancer vaccines, oncolytic virus therapies and cancer gene therapies. The Group conducts clinical trials in multiple types of cancer utilizing its GVAX cancer vaccines and oncolytic virus therapy product platforms. GVAX vaccines consist of irradiated tumor cells, genetically modified to secrete a hormone that stimulates the body's immune response to vaccines. Oncolytic virus therapies which employ genetically modified adenoviruses are engineered to selectively replicate in and kill cancer cells.
|
|
| |
Wright Quality Rating:
CDNN Rating Explanations |
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (10/9/2009):
.31
(Figures in
U.S. Dollars) |
|
1 Week |
-7.4% |
|
13 Weeks |
-7.3% |
|
|
|
|
|
|
|
|
|
4 Weeks |
33.0% |
|
52 Weeks |
-41.2% |
|
|
|
| |
| |
Cell Genesys, Inc.
Key Data: |
|
|
|
| |
Ticker: |
CEGE |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Miscellaneous |
| |
|
| |
|
|
Sub Industry: |
Medical Services |
| |
|
| |
2008
Sales |
94,571,000
(Year Ending Jan 2009). |
Employees: |
61 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
N/A |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
N/A |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
N/A |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Cell Genesys, Inc., are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Cell Genesys, Inc. company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Cell Genesys, Inc. Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Cell Genesys, Inc.
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Cell Genesys, Inc. Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|